Doctor profile · Federal record
Dr. Daniel Kasuga, MD
Retina Specialist (Ophthalmology) Physician (CMS: Ophthalmology) · Ophthalmology Physician · Retina Specialist (Ophthalmology) Physician · El Paso, TX
- NPI 1568786176
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 17 yrs in practice
- Licensed in 3 states
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
1700 Curie Dr Ste 3800
El Paso, TX 799022985
(915) 532-3912
fax (915) 542-3436
Credentials & registration
- NPI registered
- March 2010 — 16 yrs on file
- Profile last updated
- June 17, 2020
- Year of graduation
- 2009 — 17 yrs since
- Specialty taxonomy
- 207WX0107X — NUCC code
- State licenses (3)
- Texas #Q8731 · Alabama #33313 · New Mexico #MD2016-0494
- Medicaid
- AL #161693
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1568786176. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
19,897
Distinct HCPCS
10
Medicare allowed
$3,640,166
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J2777 |
Injection, faricimab-svoa, 0.1 mg | 5,160 | 12 | $36 | |
Q5128 |
Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 3,143 | 181 | $272 | |
J2778 |
Injection, ranibizumab, 0.1 mg | 3,128 | 198 | $233 | |
92250 |
Photography of the retina | 2,172 | 667 | $35 | |
92014 |
Established patient complete exam of visual system | 1,961 | 584 | $120 | |
67028 |
Injection of drug into eye | 1,627 | 362 | $129 | |
J0178 |
Injection, aflibercept, 1 mg | 1,280 | 125 | $855 | |
J2781 |
Injection, pegcetacoplan, intravitreal, 1 mg | 497 | 21 | $151 | |
92235 |
Exam of retinal blood vessels using a special camera after injection of a dye | 278 | 268 | $129 | |
J7312 |
Injection, dexamethasone, intravitreal implant, 0.1 mg | 252 | 13 | $199 |
In context: peer comparison
Among 6 peers in El Paso Retina Specialist (Ophthalmology) Physician, average services per provider: 960. This provider delivers 21× the peer median.Open Payments
Industry payments received
All-time total
$4,079
Transactions
23
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Genentech USA, INC. | 5 | $2,623.26 | |
| Regeneron Pharmaceuticals, INC. | 4 | $337.79 | |
| Astellas Pharma US INC | 2 | $222.36 | |
| Alcon Vision LLC | 2 | $219.35 | |
| Carl Zeiss Meditec USA, INC. | 2 | $200.86 | |
| Alimera Sciences, INC. | 2 | $194.06 | |
| Regeneron Healthcare Solutions, INC. | 3 | $121.38 | |
| US Oncology Corporate, INC. | 1 | $69.62 | |
| Sandoz INC. | 1 | $68.67 | |
| Genentech, INC. | 1 | $22.09 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
495
Patients
332
Total drug cost
$19,597
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Prednisolone Acetate | Generic | 217 | 138 | $7,669 |
| Moxifloxacin (Moxifloxacin Hcl) | Brand | 129 | 105 | $5,708 |
| Cyclopentolate Hcl | Generic | 48 | 44 | $611 |
| Brimonidine Tartrate | Generic | 44 | 24 | $464 |
| Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) | Brand | 33 | 21 | $835 |
| Latanoprost | Generic | 13 | 0 | $171 |
| Combigan (Brimonidine Tartrate/Timolol) | Brand | 11 | 0 | $4,139 |
Frequently asked questions
What is Dr. Daniel Kasuga's medical specialty?
Dr. Daniel Kasuga practices Retina Specialist (Ophthalmology) Physician in El Paso, TX.
Where does Dr. Daniel Kasuga practice?
Dr. Daniel Kasuga practices at 1700 Curie Dr Ste 3800, El Paso, TX 799022985. Office phone: 9155323912.
What is Dr. Daniel Kasuga's NPI?
Dr. Daniel Kasuga's National Provider Identifier (NPI) is 1568786176, issued by NPPES.
Does Dr. Daniel Kasuga accept Medicare assignment?
Yes. Dr. Daniel Kasuga accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Daniel Kasuga commonly perform?
Top Medicare-reported procedures in 2023: Injection, faricimab-svoa, 0.1 mg (HCPCS J2777); Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg (HCPCS Q5128); Injection, ranibizumab, 0.1 mg (HCPCS J2778). Source: CMS Medicare Physician & Other Practitioners file.